Details for 2018734945

Up to date per 04.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON 5-BROM-2,6-DI(1 H-PYRAZOL-1-YL)PYRIMIDIN-4-AMIN UND NEUE SALZE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018734945

EP Publication Number

3630751

E-Number

1669814

Language

PCT Number

IB18053839

Publication Date

08.04.2020 A

27.03.2024 B1

Registration Date

27.03.2024

AT Publication Date

15.04.2024

Application Date

30.05.2018

Registration Number

Priorities

31.05.2017

PCT/CN2017/086624

IPC

C07D 403/14 20060101AFI20181207BHEP

Maximum Duration of Protection

30.05.2038

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Palobiofarma, S.L.Avenida Ernst Luch 32 TCM3-0401 08302 Mataro (Barcelona)ES

Representative

No representatives present

Inventor

CUI, Kaic/o Suzhou Novartis Pharma Technology Co. Ltd. 18 Tonglian Road Riverside Industrial Park Changshu Economic Development Zone Changshu Jiangsu 215537CN

KONG, Weiyongc/o Suzhou Novartis Pharma Technology Co. Ltd. 18 Tonglian Road Riverside Industrial Park Changshu Economic Development Zone Changshu Jiangsu 215527CN

CASTRO-PALOMINO LARIA, Julio Cesarc/o PALOBIOFARMA S.L. Avenida Ernest Luch 32 TCM2-0207 08302 Mataro (Barcelona)ES